title: Carmustine toxicity presenting as a lobar infiltrate.
abstract: Carmustine is a chemotherapeutic agent frequently employed in the treatment of malignant brain tumors. The side effect of pulmonary fibrosis occurs in 20 to 30 percent of patients receiving this drug. Herein we report a case of presumed carmustine-induced pulmonary fibrosis occurring with an unusual lobar distribution.
authors.affiliation: St. Vincent Hospital, Indianapolis.
authors.forename: D L
authors.initials: DL
authors.lastname: Patterson
authors.forename: M C
authors.initials: MC
authors.lastname: Wiemann
authors.forename: T H
authors.initials: TH
authors.lastname: Lee
authors.forename: W A
authors.initials: WA
authors.lastname: Byron
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000188:drug therapy; D002330:Carmustine / Q000009:adverse effects*; D005260:Female; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000503:physiopathology; D014797:Vital Capacity / Q000502:physiology
chemical_list: D002330:Carmustine